Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
PUT
PepsiCo
PEP
$190B
| $30.4M | 0.04% |
384,200
+44,100
| +13% | +$3.62M |
|
477
CALL
SLB Ltd
SLB
$75B
| $30.3M | 0.04% |
344,000
-70,500
| -17% | -$5.79M |
|
478
PUT
Chevron
CVX
$366B
| $30.2M | 0.04% |
249,300
-34,600
| -12% | -$4.25M |
|
479
CALL
Norfolk Southern
NSC
$75.1B
| $30.1M | 0.04% |
391,500
+23,800
| +6% | +$1.78M |
|
480
Salesforce
CRM
$158B
| $30M | 0.04% |
589,193
-377,073
| -39% | -$17.1M |
|
481
CALL
Avis
CAR
$5.02B
| $30M | 0.04% |
1,073,100
+1,030,400
| +2,413% | +$30.8M |
|
482
Conagra Brands
CAG
$7.23B
| $29.9M | 0.04% |
1,282,702
+100,120
| +8% | +$2.7M |
|
483
Sysco
SYY
$40.3B
| $29.9M | 0.04% |
966,044
+129,085
| +15% | +$4.33M |
|
484
Corning
GLW
$143B
| $29.9M | 0.04% |
2,137,315
+65,152
| +3% | +$965K |
|
|
APC
485
CALL
DELISTED
Anadarko Petroleum
APC
| $29.8M | 0.04% |
324,000
+76,800
| +31% | +$6.99M |
|
486
PUT
Altria Group
MO
$114B
| $29.8M | 0.04% |
876,500
+116,700
| +15% | +$4.11M |
|
487
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $29.7M | 0.04% |
521,794
+108,066
| +26% | +$6.28M |
|
488
Viasat
VSAT
$11.1B
| $29.7M | 0.04% |
471,754
+433,165
| +1,123% | +$29M |
|
489
PUT
Walmart Inc
WMT
$890B
| $29.7M | 0.04% |
1,219,500
-128,400
| -10% | -$3.24M |
|
|
AET
490
CALL
DELISTED
Aetna Inc
AET
| $29.6M | 0.04% |
462,000
-52,066
| -10% | -$3.34M |
|
491
Gen Digital
GEN
$17.5B
| $29.4M | 0.04% |
1,223,661
+10,023
| +0.8% | +$252K |
|
492
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $29.2M | 0.03% |
348,088
+236,502
| +212% | +$19.9M |
|
493
PPG Industries
PPG
$26.6B
| $29.1M | 0.03% |
348,440
+80,410
| +30% | +$6.43M |
|
494
PUT
Expedia Group
EXPE
$37.3B
| $29M | 0.03% |
569,050
+30,600
| +6% | +$1.64M |
|
|
PCYC
495
CALL
DELISTED
PHARMACYCLICS INC
PCYC
| $29M | 0.03% |
210,100
+147,800
| +237% | +$16.4M |
|
496
CME Group
CME
$94.8B
| $28.9M | 0.03% |
396,154
+18,420
| +5% | +$1.36M |
|
497
PUT
Sarepta Therapeutics
SRPT
$1.77B
| $28.9M | 0.03% |
615,000
-1,098,500
| -64% | -$42.3M |
|
|
LO
498
DELISTED
LORILLARD INC COM STK
LO
| $28.8M | 0.03% |
655,230
-1,881,188
| -74% | -$82.9M |
|
499
CALL
Teva Pharmaceuticals
TEVA
$41.2B
| $28.7M | 0.03% |
775,400
+6,900
| +0.9% | +$269K |
|
500
Weyerhaeuser
WY
$18.4B
| $28.6M | 0.03% |
1,022,333
+40,144
| +4% | +$1.14M |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.